top of page

NEWS

The Latest Information

Stay informed

Search

Digital Model-Driven CGT Process development - new publication

Digital Model-Driven CGT Process development - new publication

Digital Model-Driven CGT Process development - new publication

Aug 271 min read

Join Antleron at the 2nd Ansys European In Silico Pharma & Healthcare Conference

Join Antleron at the 2nd Ansys European In Silico Pharma & Healthcare Conference

Join Antleron at the 2nd Ansys European In Silico Pharma & Healthcare Conference

May 211 min read

Antleron’s CEO Jan Schrooten will deliver a presentation on bioprocessing at the 3rd GATE partnering event

Antleron’s CEO Jan Schrooten will deliver a presentation on bioprocessing at the 3rd GATE partnering event

Antleron’s CEO Jan Schrooten will deliver a presentation on bioprocessing at the 3rd GATE partnering event

Apr 21 min read

Third Trends Gazellen nomination for Antleron

Third Trends Gazellen nomination for Antleron

Third Trends Gazellen nomination for Antleron

Jan 301 min read

Gideon Wackers combines biomedical processes with engineering technology to develop innovative and scalable therapeutic bioprocess solutions

Gideon Wackers combines biomedical processes with engineering technology to develop innovative and scalable therapeutic bioprocess solutions

Gideon Wackers combines biomedical processes with engineering technology to develop innovative and scalable therapeutic bioprocess solutions

Nov 29, 20243 min read

Chemical engineer Katerina Leonida embarks on a PhD covering the DC8 project within the GEne Therapy INnovation training network (GET-IN)

Chemical engineer Katerina Leonida embarks on a PhD covering the DC8 project within the GEne Therapy INnovation training network (GET-IN)

Chemical engineer Katerina Leonida embarks on a PhD covering the DC8 project within the GEne Therapy INnovation training network (GET-IN)

Sep 13, 20243 min read

Well-equipped and integrated R&D labs for custom bioprocess development from concept to scalable production

Well-equipped and integrated R&D labs for custom bioprocess development from concept to scalable production

Well-equipped and integrated R&D labs for custom bioprocess development from concept to scalable production

Jul 23, 20242 min read

Pascale Berthet sharpens Antleron's go-to-market strategy, bolstering its growth trajectory in pharma and biotech

Pascale Berthet sharpens Antleron's go-to-market strategy, bolstering its growth trajectory in pharma and biotech

Pascale Berthet sharpens Antleron's go-to-market strategy, bolstering its growth trajectory in pharma and biotech

Jul 5, 20243 min read

Factories of the future - a far dream or close reality?

Factories of the future - a far dream or close reality?

Factories of the future - a far dream or close reality?

Jun 13, 20245 min read

Antleron & Novasign digital twin approach for scalable cell & gene therapy bioprocess development showcased at ESACT 2024

Antleron & Novasign digital twin approach for scalable cell & gene therapy bioprocess development showcased at ESACT 2024

Antleron & Novasign digital twin approach for scalable cell & gene therapy bioprocess development showcased at ESACT 2024

Jun 11, 20241 min read

Antleron CEO Jan Schrooten recognized for his scientific work

Antleron CEO Jan Schrooten recognized for his scientific work

Antleron CEO Jan Schrooten recognized for his scientific work

Jun 6, 20241 min read

David Nauwelaers strengthens the development of Antleron’s manufacturing capabilities enabling custom bioprocess scaling and GMP translation

David Nauwelaers strengthens the development of Antleron’s manufacturing capabilities enabling custom bioprocess scaling and GMP translation

David Nauwelaers strengthens the development of Antleron’s manufacturing capabilities enabling custom bioprocess scaling and GMP translation

May 31, 20243 min read

Britt Van Ballaer develops bioreactor systems in support of scalable bioprocesses and next generation therapies

Britt Van Ballaer develops bioreactor systems in support of scalable bioprocesses and next generation therapies

Britt Van Ballaer develops bioreactor systems in support of scalable bioprocesses and next generation therapies

Apr 19, 20242 min read

Digital twins fast-track bioprocess development

Digital twins fast-track bioprocess development

Digital twins fast-track bioprocess development

Apr 10, 20242 min read

Anaïs Schaschkow presents in vitro bone model at Organoid@KU Leuven Symposium

Anaïs Schaschkow presents in vitro bone model at Organoid@KU Leuven Symposium

Anaïs Schaschkow presents in vitro bone model at Organoid@KU Leuven Symposium

Apr 5, 20241 min read

Bayesian optimization accelerates cell therapy process development

Bayesian optimization accelerates cell therapy process development

Bayesian optimization accelerates cell therapy process development

Apr 5, 20241 min read

Our Antleron Fellows: a vibrant, multidisciplinary team of scientists

Our Antleron Fellows: a vibrant, multidisciplinary team of scientists

Our Antleron Fellows: a vibrant, multidisciplinary team of scientists

Mar 29, 20241 min read

Antleron and Tuatara Dx team up to revolutionize point-of-need diagnostics

Antleron and Tuatara Dx team up to revolutionize point-of-need diagnostics

Antleron and Tuatara Dx team up to revolutionize point-of-need diagnostics

Mar 4, 20241 min read

Trends Gazellen 2024 nomination for Antleron

Trends Gazellen 2024 nomination for Antleron

Trends Gazellen 2024 nomination for Antleron

Jan 8, 20241 min read

Antleron joins Flemish-Brabant advanced therapy delegation to Heidelberg-Mannheim ecosystem

Antleron joins Flemish-Brabant advanced therapy delegation to Heidelberg-Mannheim ecosystem

Antleron joins Flemish-Brabant advanced therapy delegation to Heidelberg-Mannheim ecosystem

Sep 27, 20231 min read

bottom of page